Ecolab Inc.

On the data provided, Ecolab's filings show revenue that has grown since 2020, reaching $16.08 billion in 2025 against $11.79 billion in 2020 and above the $14.91 billion reported for 2019. The growth has not carried through to operating income in the most recent year. Operating income of $2.74 billion in 2025 is slightly below $2.8 billion in 2024, though it was $1.99 billion in 2023, so the profit line has moved unevenly across the three years for which operating income is on file. The analysis is limited because this synthesis has no MD&A, no risk-factor text, and no FACT-classified news, so it cannot name the segments, product lines, programs, debt instruments, or regulatory matters that management or the 10-K describe. No forensic scores are on file, so none is assessed here. The Beneish M-Score is a screen that estimates the likelihood of earnings manipulation from changes in receivables, margins, asset quality, and similar items, and an elevated reading would call for a closer read rather than prove wrongdoing. The Piotroski F-Score counts a set of profitability, leverage, and efficiency signals. The Altman Z-Score is a bankruptcy-risk screen, and the Fog Index measures how hard a document is to read. None of these has been computed from this data, so this synthesis gives no reading on any of them. Readers may want to start with the consolidated statements of income and cash flows in the most recent 10-K, then the MD&A discussion of operating income, to understand what drove the 2025 change. The risk-factor section would show which exposures management itself identifies. Those sources would help test whether the revenue growth shown here reflects durable demand or whether price and cost effects account for more of it than the headline numbers suggest.

Catalyst.The only company data provided for this synthesis is annual income-statement figures, so the business drivers cannot be confirmed from filing text here. Reported revenues rose from $15.74 billion in 2024 to $16.08 billion in 2025, an increase of about 2.2 percent, after growing from $15.32 billion in 2023 to $15.74 billion in 2024, roughly 2.7 percent. Operating income, by contrast, eased from $2.8 billion in 2024 to $2.74 billion in 2025, a decline of about 2.1 percent. The MD&A that would explain the reasons for these movements is not on file, so no specific product, segment, or market driver is named here.

Hidden risk.The notable tension in the provided numbers is that revenue grew while operating income fell. Operating income was $2.74 billion on $16.08 billion of revenue in 2025, an operating margin of about 17.0 percent, compared with about 17.8 percent in 2024 ($2.8 billion on $15.74 billion). Subtracting operating income from revenue implies operating costs rose from about $12.94 billion to about $13.34 billion, roughly 3.1 percent, faster than the 2.2 percent revenue growth. The data does not show why. Risk-factor text is not on file, so the filing's own description of exposures cannot be checked here. Readers may want to look at the risk-factor section and MD&A in the most recent 10-K to see what management attributes the margin change to.